Literature DB >> 16527486

Recent developments in the identification of novel oxazolidinone antibacterial agents.

Adam R Renslo1, Gary W Luehr, Mikhail F Gordeev.   

Abstract

The oxazolidinones are a promising new class of synthetic antibacterial agents. Here, we review recent efforts directed at the discovery of new antibacterial compounds of this class. New structures and structure-activity relationships (SAR) are discussed in the context of earlier work in the field. Key issues of potency, spectrum, selectivity, in vivo efficacy, and pharmacokinetic profile of the new analogs are addressed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527486     DOI: 10.1016/j.bmc.2006.01.068

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

Review 1.  The chemical biology of new drugs in the development for tuberculosis.

Authors:  Clifton E Barry; John S Blanchard
Journal:  Curr Opin Chem Biol       Date:  2010-05-07       Impact factor: 8.822

2.  Characterization of the Core Ribosomal Binding Region for the Oxazolidone Family of Antibiotics Using Cryo-EM.

Authors:  Alexander Wright; Kieran Deane-Alder; Edward Marschall; Rebecca Bamert; Hari Venugopal; Trevor Lithgow; David W Lupton; Matthew J Belousoff
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-13

3.  Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.

Authors:  Jeffrey B Locke; John Finn; Mark Hilgers; Gracia Morales; Shahad Rahawi; Kedar G C; Juan José Picazo; Weonbin Im; Karen Joy Shaw; Jeffrey L Stein
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

4.  Antifouling activity of bromotyrosine-derived sponge metabolites and synthetic analogues.

Authors:  Sofia Ortlepp; Martin Sjögren; Mia Dahlström; Horst Weber; Rainer Ebel; RuAngelie Edrada; Carsten Thoms; Peter Schupp; Lars Bohlin; Peter Proksch
Journal:  Mar Biotechnol (NY)       Date:  2007-08-23       Impact factor: 3.619

5.  Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents.

Authors:  Dianqing Sun; Robin B Lee; Rajendra P Tangallapally; Richard E Lee
Journal:  Eur J Med Chem       Date:  2008-04-29       Impact factor: 6.514

6.  Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure.

Authors:  Mahesh S Deshmukh; Nidhi Jain
Journal:  ACS Med Chem Lett       Date:  2017-09-28       Impact factor: 4.345

7.  Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.

Authors:  Cheng Ji; Weimin Lin; Garrett C Moraski; Jane A Thanassi; Michael J Pucci; Scott G Franzblau; Ute Möllmann; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-04-18       Impact factor: 3.641

8.  Discovery of novel isoxazolines as anti-tuberculosis agents.

Authors:  Rajendra P Tangallapally; Dianqing Sun; Nageshwar Budha; Robin E B Lee; Anne J M Lenaerts; Bernd Meibohm; Richard E Lee
Journal:  Bioorg Med Chem Lett       Date:  2007-09-15       Impact factor: 2.823

9.  Syntheses and antibacterial activity studies of new oxazolidinones from nitroso Diels-Alder chemistry.

Authors:  Shanshan Yan; Marvin J Miller; Timothy A Wencewicz; Ute Möllmann
Journal:  Bioorg Med Chem Lett       Date:  2009-10-08       Impact factor: 2.823

10.  (Z)-5-Benzyl-idene-3-butyl-4-phenyl-1,3-oxazolidin-2-one.

Authors:  Jin-Wu Zhao; Jing-Xiu Xu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.